Sanofi and GSK report successful efficacy results against Omicron
COVID-19 Beta-containing vaccine provides 75.1% efficacy in participants previously infected with coronavirus
24th June 2022
COVID-19 Beta-containing vaccine provides 75.1% efficacy in participants previously infected with coronavirus
24th June 2022
MHRA extends UCB’s therapy for the treatment of partial-onset seizures
24th June 2022
Global surveillance systems show that recorded cases do not include any deaths
23rd June 2022
The company has renewed its pledge to eliminate neglected tropical diseases and malaria over five years
23rd June 2022
Novartis receives approval from the European Commission for Tabrecta for the treatment of non-small cell lung cancer
22nd June 2022
The MS Society responds as MS therapy Fampyra is rejected
22nd June 2022
Eplontersen significantly improved patient-reported quality of life following successful research
21st June 2022
Pre-clinical screening technology could increase cancer test numbers by 50 times
21st June 2022
The joint aim of the companies was to provide vaccines to vulnerable communities
20th June 2022
The discovery may lead to development of drugs that halt disease progression and stop memory loss
20th June 2022
Therapy represents the first STAMP inhibitor for patients with chronic myeloid leukaemia
17th June 2022
Verzenios in combination with endocrine treats people with early breast cancer who are at high-risk of recurrence
17th June 2022
The MT-RNR1 test was assessed under NICE’s diagnostics assessment programme
16th June 2022
The companies will focus on the development of biomarkers for chronic diseases
16th June 2022
The deal will boost CatSci’s ability to deliver best-in-class medicines to patients worldwide
15th June 2022